Compassionate use of REGN-COV2 in the treatment of COVID-19 in a patient with impaired humoral immunity

BACKGROUND: The role of antibodies in coronavirus disease 2019 (COVID-19) in patients with X-linked agammaglobulinaemia (XLA) has yet to be characterised and clinical courses observed in this cohort of patients have been heterogeneous. Whilst some exhibit spontaneous recovery, others have experience...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Hanna, Salkeld, Jo, Agarwal, Sangita, Goodman, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of British Infection Association. 2021
Materias:
Case Reports and Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373583/
https://www.ncbi.nlm.nih.gov/pubmed/34426799
http://dx.doi.org/10.1016/j.clinpr.2021.100089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373583/
https://www.ncbi.nlm.nih.gov/pubmed/34426799
http://dx.doi.org/10.1016/j.clinpr.2021.100089

Ejemplares similares